NRXP

NRX PHARMACEUTICALS INC

NRXP·629444209·US·Common Stock·Healthcare - Biotechnology-13D/G

NRXP (NRX PHARMACEUTICALS INC) is held by 33 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($6.6M), AMERIPRISE FINANCIAL INC ($3.8M), BALYASNY ASSET MANAGEMENT L.P. ($3.7M). Net institutional sentiment: Bullish.

33
Holders
$26.5M
Total Value
82% (33)
Consensus
27 buying - 6 selling
13F: Insider & Congress: Updated regularly
NRXP

Smart Money Verdict

View all
Loading verdict
Held by 33 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists May 15, 2026 · Congress none

ActivistANAnson Funds Management LP4.9%May 15, 2026
ActivistBThe B Group, Inc.12.6%Aug 21, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.6M(+39.5%)$6.6M0.0%+41.33%
36
New
928,728$3.8M0.0%-15.40%
37
New
893,864$3.7M0.0%-15.40%
37
New
680,043$2.8M0.0%-15.40%
36
Increased
454,418(+14.3%)$1.9M0.0%+25.51%
29
Increased
423,115(+1577.2%)$1.7M0.0%-12.77%
41
Increased
314,659(+1.5%)$1.3M0.0%-64.75%
26
Increased
220,460(+122.7%)$901,6810.0%+3.06%
27
New
194,580$795,8310.0%-15.40%
34
Increased
182,718(+7.8%)$747,3170.0%+76.11%
27
Increased
119,018(+169.6%)$486,7840.0%-6.59%
26
Increased
116,084(+33.5%)$474,7840.0%+4.06%
21
Increased
62,951(+44.8%)$257,4700.0%+32.17%
21
New
43,605$178,3440.0%-15.40%
31
Increased
40,901(+307.9%)$167,2850.0%-8.47%
25
New
38,600$157,8740.0%-15.40%
31
New
26,429$108,0950.0%-15.40%
30
New
20,000$81,8000.0%-15.40%
30
New
19,308$78,9700.0%-15.40%
30
Decreased
18,545(-76.5%)$75,8490.0%+92.22%
0

Showing 1-20 of 35

1 / 2
NRXPNRXPNRX PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used